Structure and Function of ADAMTS13 Metalloprotease
ADAMTS13 金属蛋白酶的结构和功能
基本信息
- 批准号:7540945
- 负责人:
- 金额:$ 31.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-12-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:ADAMTSAcidsActive SitesAddressAdultAffinityAlanineAnabolismApicalAspartic AcidAutoantibodiesBasolateral Sorting SignalBindingBinding SitesBiologicalBiological AssayBlood CirculationCellular MorphologyChimeric ProteinsCleaved cellClinicalDeletion MutagenesisDisintegrin DomainDissociationEnzymesExhibitsGenesGlutamineGoalsGreen Fluorescent ProteinsHemostatic functionIdiopathic Thrombocytopenic PurpuraImmunoassayIndiumIntegrin BindingKineticsLabelLengthLinkMDCK cellMacroglobulinsMetalloproteasesMutagenesisOligosaccharidesOutcomePatientsPeptide HydrolasesPeptidesPlasmaPlasma ExchangePoint MutationPreventionProteinsRadiolabeledRecombinantsRegulationResearchResearch PersonnelRoleSignal TransductionSiteSorting - Cell MovementSpecificityStructureSurface Plasmon ResonanceSyndromeThrombocytopenic PurpuraThrombosisThrombospondin 1Thrombotic Thrombocytopenic PurpuraTimeWestern BlottingZincanalogbasedomain mappingmutantprogramsradioligandradiotracerresearch studytoolvon Willebrand Factor
项目摘要
DESCRIPTION (provided by applicant): The catastrophic complications due to deficiency in plasma metalloprotease (ADAMTS13) highlight the biological importance of this protease in regulation of hemostasis and prevention of thrombosis in microvascular circulation that occurs in the thrombotic thrombocytopenic purpura (TTP) syndrome. Identification of the gene encoding ADAMTS13 metalloprotease and determination of the structure elements in the encoded protein have opened a new era in understanding of the roles of a zinc metalloprotease in regulation of hemostasis and thrombosis, and provided the essential tools to address the fundamental (patho)biological questions concerning ADAMTS13 including its biosynthesis, activation, substrate recognition, intracellular sorting and autoantibody interaction. The goals of the proposed research are: Specific Aim 1. To determine ADAMTS13 substrate recognition by 1) analyzing the proteolytic activity of wild type ADAMTS13 and various mutants of ADAMTS13 toward von Willebrand factor and its analog, VWF73; 2) determining the binding kinetics between VWF or VWF73 and wild type or mutant ADAMTS13 by radioligand binding and surface plasmon resonance assays. Specific Aim 2. To determine intracellular sorting of ADAMTS13 by 1) determining the polarity of full-length and mutant ADAMTS13 secretion in MDCK cells; 2) determining the sorting signal and mechanisms by which ADAMTS13 is sorted; 3) determining the effect of point mutations or truncations of ADAMTS13 gene found in patients with congenital TTP on the polarity of ADAMTS13 secretion. Specific Aim 3. To determine the domains (or sites) of ADATMTS13 to which anti-ADAMTS13 autoantibodies bind and the kinetic parameters (affinity and specificity) of interaction between ADAMTS13 metalloprotease and anti-ADAMTS13 autoantibodies, and to correlate the clinical course and outcome to the distinct type of anti-ADAMTS autoantibodies identified in patients with TTP.
描述(由申请人提供):由于血浆金属蛋白酶缺乏引起的灾难性并发症(ADAMTS13)突出了这种酶在调节血栓性血小板减少性紫癜(TTP)综合征中的止血和预防微血管循环中血栓形成方面的生物学重要性。ADAMTS13金属蛋白酶编码基因的鉴定和编码蛋白中结构元素的测定为理解锌金属蛋白酶在止血和血栓形成中的作用开辟了一个新的时代,并为解决ADAMTS13的生物合成、激活、底物识别、细胞内分选和自身抗体相互作用等基本生物学问题提供了必要的工具。本研究的目标是:1.通过分析野生型ADAMTS13及其不同突变体对von Willebrand因子及其类似物VWF73的蛋白降解活性,确定ADAMTS13底物的识别能力;2)通过放射性配基结合和表面等离子体共振分析,确定VWF或VWF73与野生型或突变型ADAMTS13的结合动力学。确定ADAMTS13的细胞内分选:1)确定MDCK细胞中全长和突变的ADAMTS13分泌的极性;2)确定ADAMTS13的分选信号和分选机制;3)确定先天性TTP患者中发现的ADAMTS13基因点突变或截短对ADAMTS13分泌的极性的影响。具体目的3.确定抗ADAMTS13自身抗体与ADATMTS13结合的区域(或部位)以及ADAMTS13金属蛋白酶与抗ADAMTS13自身抗体相互作用的动力学参数(亲和力和特异性),并将TTP患者的临床病程和转归与不同类型的抗ADAMTS13自身抗体相关联。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A team player: the disintegrin domain of ADAMTS13.
团队合作者:ADAMTS13 的解整合素结构域。
- DOI:10.1182/blood-2009-03-211300
- 发表时间:2009
- 期刊:
- 影响因子:20.3
- 作者:Zheng,XLong
- 通讯作者:Zheng,XLong
Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
- DOI:10.1016/j.leukres.2013.09.019
- 发表时间:2013-12
- 期刊:
- 影响因子:2.7
- 作者:Zhang XH;Feng R;Lv M;Jiang Q;Zhu HH;Qing YZ;Bao JL;Huang XJ;Zheng XL
- 通讯作者:Zheng XL
Thromboelastography of patients after fontan compared with healthy children.
Fontan 治疗后患者与健康儿童的血栓弹力图比较。
- DOI:10.1007/s00246-009-9434-1
- 发表时间:2009
- 期刊:
- 影响因子:1.6
- 作者:Raffini,Leslie;Schwed,Alexander;Zheng,XLong;Tanzer,Maria;Nicolson,Susan;Gaynor,JWilliam;Jobes,David
- 通讯作者:Jobes,David
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
X. Long Zheng其他文献
X. Long Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('X. Long Zheng', 18)}}的其他基金
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
获得性血栓性血小板减少性紫癜的新疗法
- 批准号:
10200519 - 财政年份:2019
- 资助金额:
$ 31.48万 - 项目类别:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
获得性血栓性血小板减少性紫癜的新疗法
- 批准号:
10372208 - 财政年份:2019
- 资助金额:
$ 31.48万 - 项目类别:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
获得性血栓性血小板减少性紫癜的新疗法
- 批准号:
9764787 - 财政年份:2019
- 资助金额:
$ 31.48万 - 项目类别:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
获得性血栓性血小板减少性紫癜的新疗法
- 批准号:
10231274 - 财政年份:2019
- 资助金额:
$ 31.48万 - 项目类别:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
获得性血栓性血小板减少性紫癜的新疗法
- 批准号:
8504051 - 财政年份:2013
- 资助金额:
$ 31.48万 - 项目类别:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
获得性血栓性血小板减少性紫癜的新疗法
- 批准号:
8669155 - 财政年份:2013
- 资助金额:
$ 31.48万 - 项目类别:
Cofactor-Dependent Regulation of ADAMTS13 Function
ADAMTS13 功能的辅因子依赖性调节
- 批准号:
7663368 - 财政年份:2009
- 资助金额:
$ 31.48万 - 项目类别:
Structure and Function of ADAMTS13 Metalloprotease
ADAMTS13 金属蛋白酶的结构和功能
- 批准号:
6988488 - 财政年份:2004
- 资助金额:
$ 31.48万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 31.48万 - 项目类别:
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 31.48万 - 项目类别:
Continuing Grant
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 31.48万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 31.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 31.48万 - 项目类别:
Operating Grants
Metabolomic profiles of responders and non-responders to an omega-3 fatty acids supplementation.
对 omega-3 脂肪酸补充剂有反应和无反应者的代谢组学特征。
- 批准号:
495594 - 财政年份:2023
- 资助金额:
$ 31.48万 - 项目类别:
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 31.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 31.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 31.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 31.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)